Wellgistics Health Statistics
Total Valuation
WGRX has a market cap or net worth of $7.65 million. The enterprise value is $36.33 million.
Important Dates
The last earnings date was Tuesday, May 19, 2026, after market close.
| Earnings Date | May 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
WGRX has 2.51 million shares outstanding. The number of shares has increased by 71.58% in one year.
| Current Share Class | 2.51M |
| Shares Outstanding | 2.51M |
| Shares Change (YoY) | +71.58% |
| Shares Change (QoQ) | +8.34% |
| Owned by Insiders (%) | 51.15% |
| Owned by Institutions (%) | 3.76% |
| Float | 814,460 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.05 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -79.18% |
| Return on Invested Capital (ROIC) | -159.60% |
| Return on Capital Employed (ROCE) | 2,697.11% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.32 |
| Inventory Turnover | 3.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.37% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -93.37% |
| 50-Day Moving Average | 4.78 |
| 200-Day Moving Average | 19.62 |
| Relative Strength Index (RSI) | 39.52 |
| Average Volume (20 Days) | 66,328 |
Short Selling Information
The latest short interest is 444,588, so 17.72% of the outstanding shares have been sold short.
| Short Interest | 444,588 |
| Short Previous Month | 10.20M |
| Short % of Shares Out | 17.72% |
| Short % of Float | 54.59% |
| Short Ratio (days to cover) | 0.07 |
Income Statement
In the last 12 months, WGRX had revenue of $14.03 million and -$76.59 million in losses. Loss per share was -$45.50.
| Revenue | 14.03M |
| Gross Profit | -6.95M |
| Operating Income | -55.86M |
| Pretax Income | -76.59M |
| Net Income | -76.59M |
| EBITDA | -53.10M |
| EBIT | -55.86M |
| Loss Per Share | -$45.50 |
Full Income StatementBalance Sheet
The company has $51,730 in cash and $28.73 million in debt, giving a net cash position of -$28.68 million or -$11.43 per share.
| Cash & Cash Equivalents | 51,730 |
| Total Debt | 28.73M |
| Net Cash | -28.68M |
| Net Cash Per Share | -$11.43 |
| Equity (Book Value) | -15.06M |
| Book Value Per Share | -6.32 |
| Working Capital | -29.44M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.92M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.77M |
| Net Borrowing | 810,892 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | -49.51% |
| Operating Margin | -398.05% |
| Pretax Margin | -545.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |